ANDA 202144, held by Actavis Labs Fl Inc. Hydromorphone Hydrochloride.
As of Nov 16, 2026, ANDA 202144 (Hydromorphone Hydrochloride), held by Actavis Labs Fl Inc, was first approved by FDA on May 12, 2014, with 15 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 12, 2014 | Original application | Approved |
| Hydromorphone Hydrochloride8MG · tablet, extended release;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride12MG · tablet, extended release;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride16MG · tablet, extended release;oral | Hydromorphone Hydrochloride | Discontinued |
| Hydromorphone Hydrochloride32MG · tablet, extended release;oral | Hydromorphone Hydrochloride | Discontinued |
| Jun 18, 2026 | Supplement 23REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 22Labeling · Standard review | Approved | None posted |
| Dec 22, 2025 | Supplement 20Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 21REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 19Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 18Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 16Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 15REMS | Approved | None posted |
| Nov 7, 2017 | Supplement 14Labeling · Standard review | Approved | None posted |
| May 26, 2017 | Supplement 13REMS | Approved | None posted |
| Sep 30, 2016 | Supplement 10REMS | Approved | None posted |
| Jun 30, 2016 | Supplement 6Manufacturing | Approved | |
| Apr 20, 2016 | Supplement 8REMS | Approved | None posted |
| Jun 26, 2015 | Supplement 7REMS | Approved | None posted |
| Aug 19, 2014 | Supplement 5REMS | Approved | None posted |
| May 12, 2014 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters